Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major task to win over investors, accelerate the French company's ...

GSK’s own proprietary platform is called Cogito Forge. It is not a standard AI search model, but one that uses ‘agents’ that can debate with each other. One proposes a target, another simulates its ...

By Bhanvi Satija and Maggie Fick LONDON, Feb 13 (Reuters) - Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major task to win over investors, accelerate the French company's stalled drug ...

In fact, last year Lilly's medication -- called tirzepatide, which treats both type 2 diabetes and obesity -- became the best ...

New independent director Phillip Balatsos brings commercial and capital markets expertise to drive development ...

The FDA has rejected a rare disease therapy from Disc Medicine, an early recipient of a commissioner's voucher from the ...

FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong ...

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/trial-workflows ...

Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

Fiji is in the grips of the fastest growing HIV outbreak in the world, with half of those infected contracting the virus from sharing needles ...

A new type of tissue model that more accurately mimics the architecture of the liver could help develop drugs to treat MASLD.